What are the risks of prescribing both a beta-blocker and a calcium channel blocker?
Metadata[+] Show full item record
What are the risks of prescribing both a beta-blocker and a calcium channel blocker? Bottom line: When amlodipine or diltiazem are added to beta-blocker therapy for the treatment of stable inducible angina, 0.9% to 4.5% of patients will discontinue therapy due to intolerable dizziness and about 20% of patients will experience cardiovascular adverse events (AEs) (SOR: B, RCTs). About 0.74% of hospital admissions may be due in part to adverse reactions from such drug combinations (SOR: C, single prospective case series).
Evidence-based practice 18, no. 07 (2015): 14